Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Fenton

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Functional & Integrative Genomics|May 18, 2023
Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitisWei Meng, Kay-Martin Johnsen, Christopher G Fenton, et al.
Molecular Oncology|December 9, 2009
New specific molecular targets for radio-chemotherapy of rectal cancerKristin Snipstad, Christopher G Fenton, Jørn Kjaeve, et al.
Journal of Crohn'S & Colitis|October 18, 2017
Transcriptomic Landscape of Treatment-Naïve Ulcerative ColitisHagar Taman, Christopher G Fenton, Inga V Hensel, et al.
Scientific Reports|March 22, 2024
DNA methylation fine-tunes pro-and anti-inflammatory signalling pathways in inactive ulcerative colitis tissue biopsiesWei Meng, Christopher G Fenton, Kay-Martin Johnsen, et al.
BMC Genomics|January 26, 2012
Expression profiling reveals Spot 42 small RNA as a key regulator in the central metabolism of Aliivibrio salmonicidaGeir A Hansen, Rafi Ahmad, Erik Hjerde, et al.
Journal of Crohn'S & Colitis|August 24, 2018
Genome-wide DNA Methylation in Treatment-naïve Ulcerative ColitisHagar Taman, Christopher G Fenton, Inga V Hensel, et al.
Plos One|February 2, 2012
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancerTom Donnem, Christopher G Fenton, Kenneth Lonvik, et al.
Lupus Science & Medicine|November 15, 2014
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational studyMichele Compagno, Ole P Rekvig, Anders A Bengtsson, et al.
Nature Communications|January 3, 2023
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferationAlicia Villatoro, Vincent Cuminetti, Aurora Bernal, et al.
Nature Communications|June 30, 2023
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferationAlicia Villatoro, Vincent Cuminetti, Aurora Bernal, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Functional & Integrative Genomics|May 18, 2023
Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitisWei Meng, Kay-Martin Johnsen, Christopher G Fenton, et al.
Molecular Oncology|December 9, 2009
New specific molecular targets for radio-chemotherapy of rectal cancerKristin Snipstad, Christopher G Fenton, Jørn Kjaeve, et al.
Journal of Crohn'S & Colitis|October 18, 2017
Transcriptomic Landscape of Treatment-Naïve Ulcerative ColitisHagar Taman, Christopher G Fenton, Inga V Hensel, et al.
Scientific Reports|March 22, 2024
DNA methylation fine-tunes pro-and anti-inflammatory signalling pathways in inactive ulcerative colitis tissue biopsiesWei Meng, Christopher G Fenton, Kay-Martin Johnsen, et al.
BMC Genomics|January 26, 2012
Expression profiling reveals Spot 42 small RNA as a key regulator in the central metabolism of Aliivibrio salmonicidaGeir A Hansen, Rafi Ahmad, Erik Hjerde, et al.
Journal of Crohn'S & Colitis|August 24, 2018
Genome-wide DNA Methylation in Treatment-naïve Ulcerative ColitisHagar Taman, Christopher G Fenton, Inga V Hensel, et al.
Plos One|February 2, 2012
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancerTom Donnem, Christopher G Fenton, Kenneth Lonvik, et al.
Lupus Science & Medicine|November 15, 2014
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational studyMichele Compagno, Ole P Rekvig, Anders A Bengtsson, et al.
Nature Communications|January 3, 2023
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferationAlicia Villatoro, Vincent Cuminetti, Aurora Bernal, et al.
Nature Communications|June 30, 2023
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferationAlicia Villatoro, Vincent Cuminetti, Aurora Bernal, et al.
Pageof 2